13F-HR filed by Propel Bio Management, LLC
Propel Bio Management, LLC filed this 13F-HR for the quarter ended 2025-09-30, filed 2025-11-12, with 16 holding rows worth $99,894,525.
- Accession
- 0000898432-25-000886
- Filer
- CIK 1969764
- Filed
- 2025-11-12
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2025
A holdings report, 16 entries on the cover page, a total value of $99,894,525 stated on the cover page (in dollars after the unit check, H1), rows summing to $99,894,525 with VALUE read as dollars as filed, 13F file number 028-23914. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerSimplify Asset Management Inc.028-20937
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| PLAINS GP HLDGS L P | 72651A207 | LTD PARTNR INT A | 1,272,360 | $23,207,846 | dollars as filed | |
| ACHIEVE LIFE SCIENCES INC | 004468500 | COMMON STOCK | 3,786,425 | $11,927,239 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 228,884 | $10,867,412 | dollars as filed | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 5,124,890 | $10,249,780 | dollars as filed | |
| Applied Therapeutics Inc | 03828A101 | Common Stock | 11,285,420 | $6,826,551 | dollars as filed | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 552,927 | $6,507,951 | dollars as filed | |
| ABEONA THERAPEUTICS INC | 00289Y206 | COM NEW | 974,022 | $5,142,836 | dollars as filed | |
| DELCATH SYSTEMS INC | 24661P807 | COMMON STOCK | 438,509 | $4,713,972 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 155,000 | $4,009,850 | dollars as filed | |
| Tscan Therapeutics Inc | 89854M101 | COM | 1,932,304 | $3,516,793 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 510,000 | $2,922,300 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268306 | COMMON STOCK | 49,000 | $2,788,100 | dollars as filed | |
| JASPER THERAPEUTICS INC | 471871202 | COM NEW | 1,028,806 | $2,448,558 | dollars as filed | |
| ZEVRA THERAPEUTICS INC COM NEW | 488445206 | Stock | 231,874 | $2,205,122 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 90,000 | $1,942,200 | dollars as filed | |
| LeonaBio Inc | 04746L203 | COM | 149,279 | $618,015 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000898432-25-000886 | this filing | 2025-11-12 | acceptance time not in the bulk data set |